These studies suggest that hepatic Nampt deficiency induced Nampt/NAD/SIRT1 pathway inactivation is a critical mechanism for HFD-induced hepatic steatosis and abnormal liver lipid metabolism. The gene discussed is NAMPT; the disease is fatty liver disease.